CHS Inc. narrows losses, Q1 operating revenues up 1%

Net operating revenues totaled $3.140 billion, a slight increase from $3.108 billion in the prior year, exceeding the estimated $3.093 billion. CHS booked a $41 million in net loss, an improvement from $51 million loss recorded in Q1 2023.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...